1. Home
  2. Alle Unternehmen
  3. Lineage Cell Therapeutics
  4. Kennzahlen
  5. EBITDA per Share
Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
€ 1.37 4.93%

Geschäftsbericht 2025
hinzugefügt 05.03.2026

report update icon

Lineage Cell Therapeutics EBITDA per Share 2011-2026 | LCTX

EBITDA per Share Jährlich Lineage Cell Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.16 -0.1 -0.03 -0.04 -0.17 -0.162 -0.246 -0.297 -0.326 -0.557 -0.746 -0.636 -0.638 -0.45 -0.344

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
-0.03 -0.746 -0.327

EBITDA per Share Vierteljährlich Lineage Cell Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-0.02 -0.09 -0.03 - -0.02 -0.03 -0.04 - -0.04 -0.03 -0.04 - 0.82 0.84 -0.04 -0.17 -0.04 -0.04 -43.3 -0.04 -0.04 -41.3 -0.05 -0.05 -0.05 -0.07 -0.09 -0.08 -0.08 -0.07 -0.09 -0.08 -0.08 -0.08 -104 -0.11 -83.3 -146 -258 -0.24 -206 -166 -0.17 -0.18 -0.17 -0.2 -0.19 -0.52 -0.18 -0.15 -0.16 -0.14 -0.11 -0.12 -0.12 -0.11 -0.08 -0.1 -0.08

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
0.84 -258 -18.8

EBITDA per Share anderer Aktien in der Pharmaeinzelhändler

Name EBITDA per Share Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
 		-15.2 - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
 		-188 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		-6.85 - - $ 86.2 M usaUSA
AlloVir AlloVir
ALVR
 		-3.02 - 4.14 % $ 49.1 M usaUSA
Amgen Amgen
AMGN
 		26.5 $ 345.82 1.71 % $ 186 B usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
 		1.44 $ 12.61 2.35 % $ 3.95 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		-3.2 - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		-0.77 - - $ 8.42 M usaUSA
argenx SE argenx SE
ARGX
 		-6.83 $ 776.24 1.41 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
 		0.08 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		6.75 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		-2.24 - 2.54 % $ 160 B franceFrance
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		-0.09 $ 24.35 4.64 % $ 3.1 B usaUSA
Biophytis SA Biophytis SA
BPTS
 		-0.23 - -13.47 % $ 169 M franceFrance
AVROBIO AVROBIO
AVRO
 		0.24 - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		-2.42 - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
 		0.74 - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
 		-0.09 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.22 - -1.52 % $ 24.7 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		-0.99 $ 1.44 5.51 % $ 383 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		0.42 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		-1.68 $ 3.85 2.39 % $ 9.26 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		-0.95 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
 		-5.96 - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		-0.39 $ 2.74 6.42 % $ 17.2 M usaUSA
BioNTech SE BioNTech SE
BNTX
 		62.6 $ 91.34 1.92 % $ 27.2 B germanyGermany
Avid Bioservices Avid Bioservices
CDMO
 		-0.12 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		-27.7 - - $ 1.41 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
 		1.11 $ 4.63 1.87 % $ 767 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		-2.69 - - - russiaRussia
Cabaletta Bio Cabaletta Bio
CABA
 		-1.7 $ 3.09 0.65 % $ 310 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		-1.42 - - $ 169 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		-0.01 $ 3.07 1.32 % $ 6.68 B israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
 		-0.08 - 5.93 % $ 314 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		-2.84 - - $ 231 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		-2.35 - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		-2.21 - - $ 401 M usaUSA
Cerus Corporation Cerus Corporation
CERS
 		-0.04 $ 1.94 5.43 % $ 370 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		-6.7 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		-0.36 - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		-0.68 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		-3.89 - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		0.01 - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		-3.85 - -4.36 % $ 27 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
 		-8.73 $ 2.92 6.18 % $ 7.62 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		-2.46 - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		-4.25 - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		-0.25 - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		-2.22 - - $ 867 M germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
 		-1.54 $ 1.68 0.6 % $ 197 M usaUSA